« We are committed to meeting your project’s timelines. »

Project Coordinator
Dermatology clinical trial expert offering cro services for phase i, phase 2, phase 3 and phase 4 clinical study
« As your business partner, I'll facilitate in defining your project scope. »

VP, Business Development
« We capitalize on our knowledge of dermatology to generate relevant clinical research data. »

SAS Programmer
« I’ll guarantee continuous oversight of your clinical program to maximize development efficiencies. »

Associate Project Manager

PUTTING YOUR CLINICAL DEVELOPMENT AT THE CENTER OF OUR SERVICES OFFERING

You can count on our end-to-end dermatology expertise to optimize the management of your clinical programs. We allocate resources, teams and technologies to support your projects in a way that optimizes quality, timelines, outcomes and ultimately enhances your studies' probability of success. In short, we leverage our 20+ years of dermatology clinical research experience to assist you in your journey to treatment discovery.

LATE-PHASE STUDIES (PHASE IIb-III)

No matter how complex your study is, our all-inclusive services will help you achieve a streamlined clinical development for your phase IIb – III studies.

Our dermatology experts proactively evaluate protocol and recruitment objectives to successfully address challenges surrounding late-phase trials, namely stringent regulatory requirements, patient and site recruitment challenges, complex protocol designs and procedures, and patient-reported outcomes.

Our problem-solving approach is designed to help you manage costs and mitigate risks that are inherent to your clinical projects.

Contact us

LATE-PHASE STUDIES

Large phase three dermatology clinical trial led by Dr Robert Bissonette

150+
Clinical Trials

30+
Indications

500+
Sites

60,000
Participants in our
research database

Early-Phase Studies (PHASE I-IIa)

With moving parts such as study design, regulatory requirements and clinical project optimization, early-phase clinical research is a constantly changing endeavor. Our team of dermatology experts can support your early development programs to efficiently reach relevant data milestones, both for topical and systemic compounds.

We manage phase I, Proof of Concept (POC) and First-in-Man (FIM)  studies as a single center or multicenter studies where we can leverage our own Clinical Research Unit for operational synergies.

Innovaderm strictly operates in accordance with Standard Operating Procedures (SOPs) to meet current Good Clinical Practice (GCP) from the International Conference of Harmonization (ICH) and is fully compliant with major international regulations such as the FDA (USA), Health Canada and EMA (Europe).

Contact us

Early-Phase Studies

Two employees working on study startup, study design, protocol development and clinical management.
Full-service CRO icon

Services

Expertise in dermatology clinical trials icon

Expertise

Excellent dermatology investigators icon

Investigators

About Innovaderm icon

About us